What changes will occur if you take ensifentrine-Ohtuvayre for three consecutive months?

Ensifentrine Inhalation Suspension (Ensifentrine)-Ohtuvayre is a new inhaled medication specifically designed to relieve the symptoms of chronic obstructive pulmonary disease (COPD) and other related respiratory diseases. What makes it unique is its dual mechanism of action: it has a bronchodilatory effect and can also reduce respiratory inflammation through anti-inflammatory effects, thereby improving the patient's lung function and daily activities.

After three months of continuous use of exefantine, patients typically experience a series of significant improvements. First, the most obvious change is the relief of shortness of breath and dyspnea. Because exefantine can relax the smooth muscles of the respiratory tract and expand the airways, patients will feel easier to breathe during daily activities, and the symptoms of shortness of breath will be significantly improved. For patients who have long suffered from COPD, this improvement in symptoms often means they are able to carry out daily activities more easily and their quality of life is significantly improved.

In addition, exefantine has anti-inflammatory effects and can reduce chronic respiratory inflammation. Chronic obstructive pulmonary disease is often accompanied by chronic inflammation of the airways, leading to narrowing of the airways, further exacerbating symptoms such as shortness of breath and coughing. After three months of using ensefentin, the patient's airway inflammation is relieved, and symptoms such as expectoration and coughing may also be significantly improved, thereby reducing acute exacerbations of the disease.

Long-term use of exefantine may cause some adverse effects. Although most patients adapt well in the early stages of treatment, some patients may experience side effects such as dry mouth, throat irritation, and coughing, which are usually caused by irritation when the drug is aerosolized and inhaled. If side effects persist or worsen, it is recommended to communicate with your doctor in time to adjust the dose or change the treatment plan.

Reference materials:https://www.drugs.com/monograph/ensifentrine.html